PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy7 anti-mouse/human KLRG1 (MAFA), 100 μg
PE/Cy7 anti-mouse/human KLRG1 (MAFA), 25 μg
PE/Cy7 anti-mouse/rat CD126 (IL-6Rα chain), 100 μg
PE/Cy7 anti-mouse/rat CD126 (IL-6Rα chain), 25 μg
PE/Cy7 anti-mouse/rat CD29, 100 μg
PE/Cy7 anti-mouse/rat CD29, 25 μg
PE/Cy7 anti-mouse/rat CD62P (P-selectin), 100 μg
PE/Cy7 anti-mouse/rat CD62P (P-selectin), 25 μg
PE/Cy7 anti-mouse/rat/human CD27, 100 μg
PE/Cy7 anti-mouse/rat/human CD27, 25 μg
PE/Dazzle™ 594 anti-mouse CD103, 100 μg
PE/Dazzle™ 594 anti-mouse CD103, 25 μg
PE/Dazzle™ 594 anti-mouse CD107a (LAMP-1), 100 μg
PE/Dazzle™ 594 anti-mouse CD107a (LAMP-1), 25 μg
PE/Dazzle™ 594 anti-mouse CD115 (CSF-1R), 100 μg
PE/Dazzle™ 594 anti-mouse CD115 (CSF-1R), 25 μg